CDT Equity (CDT) Research & Development (2022 - 2026)
CDT Equity's Research & Development came in at $302,000 for Q2 2026, down 83.8% from $1.86 million a year earlier and down 61.2% from the prior quarter.
Powered by 
Analysis
CDT Equity (CDT) Research & Development (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CDT Equity reported Research & Development of $3.36 million, down 44.0% year-over-year; for FY2025, it came in at $5.05 million, up 49.6% from FY2024.
- Research & Development carries a three-year compound annual growth rate of 415.0% (FY2022 to FY2025).
- Going back by year, Research & Development was $3.38 million in FY2024, $90,000 in FY2023 (+143.2%) and $37,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q4 2024.
- Year-over-year, Research & Development increased in two of the last five quarters, with growth averaging 186.3%.
- Business Quant data shows CDT's Research & Development at $778,000 (Q1 2026), $746,000 (Q4 2025) and $1.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | CDT Equity | 426.40 | -6.19 Mn | - | 302,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 302,000.00 |
| Mar 31, 2026 | 778,000.00 |
| Dec 31, 2025 | 746,000.00 |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 916,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 38,000.00 |
API Access
CDT Equity Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CDT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CDT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CDT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();